✦ LIBER ✦

Prognostic factors predictive of response to bevacizumab combined with chemotherapy in recurrent ovarian cancer – A multi-institutional study

✍ Scribed by A. Alvarez-Secord; W. Huh; T. Tillmanns; K. Moore; J. Chapman; C. McClung; T. Kiet; M. Kattan; J. Java; J. Chan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Factors predictive of toxicity associate

✍ J. Chan; W. Huh; C. McClung; A. Alvarez-Secord; K. Moore; R. Previs; L. Perry; K 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 111 KB

The efficacy and safety of chemotherapy

✍ K. Fuh; A. Alvarez-Secord; W. Huh; T. Tillmanns; K. Moore; K. Bevis; A. ElNaggar 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 69 KB

A multi-institutional evaluation of fact

✍ J.D. WRIGHT; A.A. SECORD; T.M. NUMNUM; R.P. ROCCONI; M.A. POWELL; A. BERCHUCK; R 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB

Outcomes of ovarian cancer patients afte

✍ J. Chan; A. Alvarez-Secord; T. Tillmanns; K. Moore; K. Bevis; A. ElNaggar; L. Pe 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Determining surrogate endpoints predicti

✍ S. Ueda; A. Alvarez-Secord; W. Huh; T. Tillmanns; K. Moore; R. Previs; L. Perry; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 64 KB

BRCA1 is both a prognostic and predictiv

✍ Judith E. Carser; Jennifer E. Quinn; Caroline O. Michie; Eamonn J. O'Brien; W. G 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 265 KB